We value your privacy

We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.

Benefits · 7 min read

What does a GLP-1 benefit cost employers per employee in 2026?

By Kevin Wolfe, Founder & CEO

Reviewed by Kindr Health Clinical Team

Published · Updated

A practical guide to per-employee and per-participant pricing, using the 2026 KFF employer survey and worked budget examples.

Employers usually ask for one number: what will a GLP-1 benefit cost per employee? The honest answer starts with another question: per eligible employee, or per active participant? Those two denominators can produce very different invoices.

Kindr Benefits currently models a proposed $199 per active enrolled participant per month, with medication billed separately. That is not a quote for medication, health-plan claims or total cost of care. It is a program-administration model whose final scope belongs in a signed Order Form.

What does the employer market look like in 2026?

KFF’s 2026 Employer Health Benefits Survey, published October 22, 2026, found that 18% of firms with 200 or more workers covered GLP-1 agonists primarily for weight loss in their largest-enrollment plan. The rates were 16% for firms with 200–999 workers, 29% for firms with 1,000–4,999 workers and 33% for firms with 5,000 or more workers.

These are firm-level results, not the percentage of employees with coverage. KFF also reported that 40% of covering firms required a clinical-professional meeting or lifestyle-program participation. Among covering firms, 29% said the medicines had a significant impact on prescription spending; others reported moderate, minor or no impact, or did not know.

The lesson for budgeting is not “expect the same result.” It is to separate program fees, medication and employee cost sharing, then measure your own actual experience.

Per employee versus per active participant

PEPM usually means per employee per month, using a defined eligible census. If a program costs $25 PEPM and 500 employees are eligible, the monthly fee is $12,500 even if only 25 people use it.

Per active participant counts people who meet the contract’s enrollment and activity definition. At the Kindr model’s $199 rate, 25 active participants cost $4,975 per month. With 50 participants, the fee is $9,950. With 100, it is $19,900. Medication remains separate in every example.

Neither model is automatically cheaper. Compare the denominator, activation rule, minimums, proration and what happens when someone leaves or pauses.

How does the employer contribution change the employee share?

Suppose an employer contributes $149 toward the $199 monthly program fee. The employee share is $50 per active participant per month.

Active participantsTotal program feeEmployer at $149 eachEmployee share each
10$1,990$1,490$50/month
25$4,975$3,725$50/month
50$9,950$7,450$50/month

This arithmetic does not determine HSA or FSA eligibility. An account administrator decides which expenses qualify and what records are required. Medication paid to a pharmacy or manufacturer needs its own line in the employee estimate.

What should finance ask before approving a budget?

Ask for low, expected and high participation scenarios. Confirm whether medication is a pass-through, which party bills it and how price changes are communicated. Review whether clinical visits, coaching, follow-up, shipping and reporting are actually in scope.

Then reconcile the proposal with the Order Form. Look for minimum participants, setup charges, termination rules and any separate technology fee. A polished calculator cannot substitute for those terms.

Finally, do not label the difference between an assumed productivity cost and the program fee “ROI” without evidence. KFF’s survey shows variation in employer-reported spending impact, not a universal savings multiplier.

What is a practical next step?

Use the GLP-1 employer ROI calculator to test participation and contribution assumptions. It calculates costs, not promised savings. For program context, visit the GLP-1 benefits for employers hub, then save an estimate with a proposal request.

This article is educational and is not financial, legal, tax, insurance or medical advice. Final prices and scope are controlled by signed terms.

Sources

Menopause weight gain has a cause — and a protocol.

The metabolic slowdown of menopause is driven by estrogen-related insulin resistance, cortisol, and muscle loss. The kindr Metabolic Reset addresses all three.

See the Metabolic Reset →On a GLP-1? Start here →
Prescription weight care → talk to a physician

Medically reviewed by Kindr Health Clinical Team
Last updated: November 15, 2026

Continue across the Kindr entity graph

Related evidence, peptides, and clinical tools on the same topic.

This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Keep reading

Research

Hormone therapy dispensing has more than doubled: what the new JAMA data mean for you

A new JAMA analysis of pharmacy dispensing, as reported by Science News, finds monthly hormone therapy dispensing to women aged 40 to 74 more than doubled since 2023, with growth in transdermal and vaginal estrogen while pills stayed flat, and we look at what that means for planning care

Research

Menopause equity: why so many women still fall through the cracks, and how to get the care you deserve

An AMWA position paper names gaps that still keep people from menopause care: training, screening, coverage, research and stigma. We look at what's changing in state law, a new academic post in British Columbia, and ACOG's guidance, and we offer a practical checklist for getting evaluated.

Research

Menopause care is going mainstream in state law: what's changing on coverage, education and work

Statehouses are moving on menopause coverage, education and work: what Illinois has enacted, what is pending in Pennsylvania, and what to ask your insurer. A federal survey also shows how few symptomatic women ages 40 to 60 currently take a prescription, and we look at how ACOG's new guidance fits in.

Explore your next step

Kindr Care is being updated, and the exact clinical process will depend on the current care pathway.

Explore care options →